<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04402346</url>
  </required_header>
  <id_info>
    <org_study_id>HMar_RF_transection_pancreas</org_study_id>
    <nct_id>NCT04402346</nct_id>
  </id_info>
  <brief_title>RADIOFREQUENCY-ASSISTED TRANSECTION OF THE PANCREAS VS STAPLER</brief_title>
  <acronym>TRANSPAIRE</acronym>
  <official_title>RADIOFREQUENCY-ASSISTED TRANSECTION OF THE PANCREAS VS STAPLER. A PHASE III RANDOMIZED CLINICAL TRIAL</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Patricia Sanchez Velazquez</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital del Mar</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Main objective: The main end-point of this study is to compare in a randomized clinical trial&#xD;
      that radiofrequency-assisted pancreas transection (RF) reduces the incidence of postoperative&#xD;
      pancreatic fistula (POPF) compared to the classical method of transection (stapler). As&#xD;
      secondary end-points, other clinical and demographic variables of the patients will be&#xD;
      evaluated (sex, age, ASA classification, consistency of the pancreas, as well as the type of&#xD;
      procedure, open or laparoscopic surgery, estimated intraoperative bleeding, pancreatic duct&#xD;
      size, duration of intervention, type of tumor and quality of lymphatic resection).&#xD;
      Methodology: Phase III prospective multicenter study in patients undergoing distal&#xD;
      pancreatectomy for any origin. All consecutive patients who undergo a distal pancreatectomy&#xD;
      for any cause in a multicenter setting will be included. A simple randomization of the&#xD;
      participants to the RFA group or to the control group (stapler) will be carried out. The&#xD;
      incidence of pancreatic fistula will be assessed as main variable; predictive multivariable&#xD;
      models with multiple regression for quantitative variables, logistic regression for&#xD;
      categorical variables and Cox regression for survival analyzes. In addition to histological&#xD;
      study, molecular analysis of resection specimen and clinical and radiological follow-up with&#xD;
      volumetry of necrosis in the area of post-pancreatectomy transection will be performed.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 15, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pancreas fistula</measure>
    <time_frame>90 days follow-up</time_frame>
    <description>Defined by the updated 2016 ISGPF definition</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>In-hospital Mortality</measure>
    <time_frame>In-Hospital (30 days)</time_frame>
    <description>30 days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Morbidity</measure>
    <time_frame>90 days follow-up</time_frame>
    <description>In terms of Clavien-Dindo and CCI classification</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">75</enrollment>
  <condition>Pancreas; Fistula</condition>
  <arm_group>
    <arm_group_label>Radiofrequency-assisted</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Stapler</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Radiofrequency-assisted pancreas transection</intervention_name>
    <description>Transection of the pancreas in distal pancreatectomy by applying a radio frequency device</description>
    <arm_group_label>Radiofrequency-assisted</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Stapler assisted pancreas transection</intervention_name>
    <description>Transection of the pancreas in distal pancreatectomy by applying a stapler device with/without seamguard</description>
    <arm_group_label>Stapler</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Solid or cystic, benign or malign pancreas neoplasms.&#xD;
&#xD;
          -  Patients undergoing a distal pancreatectomy, i.e pancreas transection beyond &gt; 2 cm&#xD;
             from the SMV (assessed by computer tomography or RM) with or without splenectomy&#xD;
&#xD;
          -  Both open and laparoscopic approaches are valid.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients who required a pancreatectomy with transection at the level of the neck.&#xD;
&#xD;
          -  Non-intervention group: only stapler transection will be accepted, other pancreatic&#xD;
             transection methods will be excluded.&#xD;
&#xD;
          -  Patients ASA≥IV&#xD;
&#xD;
          -  Absence of informed consent&#xD;
&#xD;
          -  Underage (&lt;18 years)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Patricia Sánchez-Velázquez, MD PhD FEBS</last_name>
    <phone>+34 932483207</phone>
    <email>Psanchezvelazquez@psmar.cat</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Fernando Burdío, MD PhD</last_name>
    <email>fburdio@hotmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Parc de Salut Mar de Barcelona- Hospital del Mar</name>
      <address>
        <city>Barcelona</city>
        <state>Cataluña</state>
        <zip>08019</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Patricia Sánchez-Velázquez, MD PhD FEBS</last_name>
      <email>Psanchezvelazquez@psmar.cat</email>
    </contact>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>May 20, 2020</study_first_submitted>
  <study_first_submitted_qc>May 20, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">May 26, 2020</study_first_posted>
  <last_update_submitted>August 23, 2021</last_update_submitted>
  <last_update_submitted_qc>August 23, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 27, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Hospital del Mar</investigator_affiliation>
    <investigator_full_name>Patricia Sanchez Velazquez</investigator_full_name>
    <investigator_title>Patricia Sánchez Velázquez MD PhD FEBS</investigator_title>
  </responsible_party>
  <keyword>Pancreas fistula</keyword>
  <keyword>Distal pancreatectomy</keyword>
  <keyword>Radiofrequency</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pancreatic Fistula</mesh_term>
    <mesh_term>Fistula</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pancrelipase</mesh_term>
    <mesh_term>Pancreatin</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

